Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines

Reference

• Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis 2014;209(7):978-81
   PubMed Web of Science ®Google Scholar
• Bart MJ, Harris SR, Advani A, et al. Global population structure and evolution of bordetella pertussis and their relationship with vaccination. MBio 2014;5(2):e01074
   PubMed Web of Science ®Google Scholar
• Hegerle N, Guiso N. Epidemiology of whooping cough & typing of Bordetella pertussis. Future Microbiol 2013;8:1391-403
   PubMedGoogle Scholar
• Higgs R, Higgins SC, Ross PJ, Mills KH. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol 2012;5(5):485-500
   PubMed Web of Science ®Google Scholar
• Guiso N. Bordetella pertussis and pertussis vaccines. Clin Infect Dis 2009;49(10):1565-9
   PubMed Web of Science ®Google Scholar
• Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18(2):326-82
   PubMed Web of Science ®Google Scholar
• Barkoff AM, Mertsola J, Guillot S, et al. Appearance of Bordetella pertussis strains not expressing vaccine antigen pertactin in Finland. Clin Vaccine Immunol 2012;19(10):1703-4
   PubMedGoogle Scholar
• Bouchez V, Brun D, Cantinelli T, et al. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. Vaccine 2009;27(43):6034-41
   PubMed Web of Science ®Google Scholar
• Hegerle N, Paris AS, Brun D, et al. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect 2012;18(9):E340-6
   PubMedGoogle Scholar
• Lam C, Octavia S, Ricafort L, et al. Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia. Emerg Infect Dis 2014;20(4):626-33
   PubMed Web of Science ®Google Scholar
• Miyaji Y, Otsuka N, Toyoizumi-Ajisaka H, et al. Genetic analysis of isolates from the 2008-2010 pertussis epidemic in Japan. PloS One 2013;8(10):e77165
   PubMedGoogle Scholar
• Otsuka N, Han HJ, Toyoizumi-Ajisaka H, et al. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS One 2012;7(2):e31985
   PubMed Web of Science ®Google Scholar
• Pawloski LC, Queenan AM, Cassiday PK, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the US. Clin Vaccine Immunol 2013;21(2):119-25
   PubMedGoogle Scholar
• Queenan AM, Cassiday PK, Evangelista A. Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 2013;368(6):583-4
   PubMedGoogle Scholar
• Quinlan T, Musser KA, Currenti SA, et al. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013. Mol Cell Probes 2014;28(4):138-40
   PubMedGoogle Scholar
• Bordet J, Gengou O. Le microbe de la coqueluche. Ann Inst Pasteur (Paris) 1906;20:731-41
   Google Scholar
• Diavatopoulos DA, Cummings CA, Schouls LM, et al. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 2005;1(4):e45
   PubMed Web of Science ®Google Scholar
• Parkhill J, Sebaihia M, Preston A, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 2003;35(1):32-40
   PubMed Web of Science ®Google Scholar
• Tizolova A, Guiso N, Guillot S. Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome. Eur J Clin Microbiol 2012;32(1):89-96
   Google Scholar
• Kurova N, Njamkepo E, Brun D, et al. Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009. Res Microbiol 2010;161(10):810-15
   PubMedGoogle Scholar
• Heininger U. Update on pertussis in children. Expert Rev Anti Infect Ther 2010;8(2):163-73
   PubMed Web of Science ®Google Scholar
• Kretzschmar M, Teunis PF, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 2010;7(6):e1000291
   PubMed Web of Science ®Google Scholar
• Cherry JD, Tan T, Wirsing von Konig CH, et al. Clinical definitions of pertussis: summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis 2012;54(12):1756-64
   PubMed Web of Science ®Google Scholar
• Dupre E, Wohlkonig A, Herrou J, et al. Characterization of the PAS domain in the sensor-kinase BvgS: mechanical role in signal transmission. BMC Microbiol 2013;13:172
   PubMedGoogle Scholar
• Decker KB, James TD, Stibitz S, Hinton DM. The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA. Microbiology 2012;158(Pt 7):1665-76
   PubMedGoogle Scholar
• Khelef N, Sakamoto H, Guiso N. Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection. Microb Pathog 1992;12(3):227-35
   PubMedGoogle Scholar
• Weiss AA, Hewlett EL, Myers GA, Falkow S. Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun 1983;42(1):33-41
   PubMedGoogle Scholar
• Carbonetti NH. Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol 2010;5(3):455-69
   PubMed Web of Science ®Google Scholar
• Fedele G, Bianco M, Ausiello CM. The virulence factors of bordetella pertussis: talented modulators of host immune response. Arch Immunol Ther Exp (Warsz) 2013;61(6):445-57
   PubMedGoogle Scholar
• Arico B, Rappuoli R. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol 1987;169(6):2847-53
   PubMed Web of Science ®Google Scholar
• Gross R, Keidel K, Schmitt K. Resemblance and divergence: the “new” members of the genus Bordetella. Med Microbiol Immunol 2010;199(3):155-63
   PubMed Web of Science ®Google Scholar
• Guermonprez P, Khelef N, Blouin E, et al. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). The J Exp Med 2001;193(9):1035-44
   PubMed Web of Science ®Google Scholar
• Gueirard P, Druilhe A, Pretolani M, Guiso N. Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect Immun 1998;66(4):1718-25
   PubMed Web of Science ®Google Scholar
• Khelef N, Zychlinsky A, Guiso N. Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect Immun 1993;61(10):4064-71
   PubMedGoogle Scholar
• Guiso N, Rocancourt M, Szatanik M, Alonso JM. Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen. Microb Pathog 1989;7(5):373-80
   PubMedGoogle Scholar
• Chenal-Francisque V, Caro V, Boursaux-Eude C, Guiso N. Genomic analysis of the adenylate cyclase-hemolysin C-terminal region of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Res Microbiol 2009;160(5):330-6
   PubMedGoogle Scholar
• Albitar-Nehme S, Basheer SM, Njamkepo E, et al. Comparison of lipopolysaccharide structures of Bordetella pertussis clinical isolates from pre- and post-vaccine era. Carbohydr Res 2013;378:56-62
   PubMedGoogle Scholar
• Caroff M, Karibian D. Structure of bacterial lipopolysaccharides. Carbohydr Res 2003;338(23):2431-47
   PubMedGoogle Scholar
• Hester SE, Park J, Goodfield LL, et al. Horizontally acquired divergent O-antigen contributes to escape from cross-immunity in the classical bordetellae. BMC Evol Biol 2013;13(1):209
   PubMedGoogle Scholar
• Caroff M, Brisson J, Martin A, Karibian D. Structure of the Bordetella pertussis 1414 endotoxin. FEBS Lett 2000;477(1-2):8-14
   PubMed Web of Science ®Google Scholar
• Marr N, Tirsoaga A, Blanot D, et al. Glucosamine found as a substituent of both phosphate groups in Bordetella lipid A backbones: role of a BvgAS-activated ArnT ortholog. J Bacteriol 2008;190(12):4281-90
   PubMed Web of Science ®Google Scholar
• Thierry-Carstensen B, Dalby T, Stevner MA, et al. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults – a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine 2013;31(45):5178-91
   PubMed Web of Science ®Google Scholar
• Poolman JT, Hallander HO. Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Rev Vaccines 2007;6(1):47-56
   PubMed Web of Science ®Google Scholar
• Perez Vidakovics ML, Lamberti Y, van der Pol WL, et al. Adenylate cyclase influences filamentous haemagglutinin-mediated attachment of Bordetella pertussis to epithelial alveolar cells. FEMS Immunol Med Microbiol 2006;48(1):140-7
   PubMedGoogle Scholar
• Lamberti Y, Alvarez Hayes J, Perez Vidakovics ML, Rodriguez ME. Cholesterol-dependent attachment of human respiratory cells by Bordetella pertussis. FEMS Immunol Med Microbiol 2009;56(2):143-50
   PubMedGoogle Scholar
• Henderson MW, Inatsuka CS, Sheets AJ, et al. Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation. Infect Immun 2012;80(6):2061-75
   PubMed Web of Science ®Google Scholar
• Zaretzky FR, Gray MC, Hewlett EL. Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin-filamentous haemagglutinin interaction. Mol Microbiol 2002;45(6):1589-98
   PubMed Web of Science ®Google Scholar
• Cummings CA, Bootsma HJ, Relman DA, Miller JF. Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol 2006;188(5):1775-85
   PubMed Web of Science ®Google Scholar
• Hot D, Antoine R, Renauld-Mongenie G, et al. Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis. Mol Genet Genomics 2003;269(4):475-86
   PubMedGoogle Scholar
• Boursaux-Eude C, Guiso N. Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Infect Immun 2000;68(8):4815-17
   PubMedGoogle Scholar
• Hijnen M, de Voer R, Mooi FR, et al. The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition. Vaccine 2007;25(31):5902-14
   PubMedGoogle Scholar
• Inatsuka CS, Xu Q, Vujkovic-Cvijin I, et al. Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun 2010;78(7):2901-9
   PubMed Web of Science ®Google Scholar
• Jacob-Dubuisson F, Locht C. The Bordetella adhesins. In: Locht FC, editors. Bordetella: molecular microbiology. Horizon Bioscience; 2007. Chapter 4):69-97
   Google Scholar
• Bassinet L, Gueirard P, Maitre B, et al. Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis. Infect Immun 2000;68(4):1934-41
   PubMed Web of Science ®Google Scholar
• Hegerle N, Guiso N. Antibody-mediated inhibition of Bordetella pertussis adenylate-cyclase hemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population. Microbiology 2014;160(Pt 5):962-9
   PubMedGoogle Scholar
• Hegerle N, Rayat L, Dore G, et al. In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Microbes Infect 2013;15(5):399-408
   PubMed Web of Science ®Google Scholar
• Khelef N, Danve B, Quentin-Millet MJ, Guiso N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun 1993;61(2):486-90
   PubMedGoogle Scholar
• WHO. Pertussis vaccines: WHO position paper – recommendations. Vaccine 2011;29(13):2355-6
   PubMedGoogle Scholar
• Zepp F, Heininger U, Mertsola J, et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011;11(7):557-70
   PubMed Web of Science ®Google Scholar
• Mooi FR, NA VDM, De Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation - two sides of the same coin. Epidemiol Infect 2013;1-10
   Google Scholar
• Advani A, Hallander HO, Dalby T, et al. Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. J Clin Microbiol 2013;51(2):422-8
   PubMed Web of Science ®Google Scholar
• Bouchez V, Caro V, Levillain E, et al. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS One 2008;3(6):e2437
   PubMed Web of Science ®Google Scholar
• Caro V, Bouchez V, Guiso N. Is the Sequenced Bordetella pertussis strain Tohama I representative of the species? J Clin Microbiol 2008;46(6):2125-8
   PubMed Web of Science ®Google Scholar
• Plotkin SA. The pertussis problem. Clin Infect Dis 2013;58(6):830-3
   PubMedGoogle Scholar
• de Gouw D, Hermans PW, Bootsma HJ, et al. Differentially expressed genes in bordetella pertussis strains belonging to a lineage which recently spread globally. PLoS One 2014;9(1):e84523
   Google Scholar
• Edwards KM, Decker MD. Pertussis vaccine. In: Vaccines. Plotkin S, Orenstein WA, Offit PA, Saunders; Philadelphia: 2008. 4th edition):471-528
   Google Scholar
• Mastrantonio P, Spigaglia P, van Oirschot H, et al. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 1999;145(Pt 8):2069-75
   PubMedGoogle Scholar
• Bouchez V, Brun D, Dore G, et al. Bordetella parapertussis isolates not expressing pertactin circulating in France. Clin Microbiol Infect 2011;17(5):675-82
   PubMed Web of Science ®Google Scholar
• Heininger U, Stehr K, Christenson P, Cherry JD. Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. Clin Infect Dis 1999;28(3):602-4
   PubMedGoogle Scholar
• Liese JG, Renner C, Stojanov S, Belohradsky BH. Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines. Arch Dis Child 2003;88(8):684-7
   PubMed Web of Science ®Google Scholar
• Long GH, Karanikas AT, Harvill ET, et al. Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis. Proc Biol Sci 2010;277(1690):2017-25
   PubMedGoogle Scholar
• Mobberley-Schuman PS, Connelly B, Weiss AA. Phagocytosis of Bordetella pertussis incubated with convalescent serum. J Infect Dis 2003;187(10):1646-53
   PubMedGoogle Scholar
• Weingart CL, Weiss AA. Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect Immun 2000;68(3):1735-9
   PubMed Web of Science ®Google Scholar
• Stefanelli P, Fazio C, Fedele G, et al. A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells. New Microbiol 2009;32(2):159-66
   PubMed Web of Science ®Google Scholar
• Bodilis H, Guiso N. Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, France. Emerg Infect Dis 2013;19(3):471-4
   PubMed Web of Science ®Google Scholar
• Hellwig SM, Rodriguez ME, Berbers GA, et al. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J Infect Dis 2003;188(5):738-42
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Complex correlates of protection after vaccination. Clin Infect Dis 2013;56(10):1458-65
   PubMed Web of Science ®Google Scholar
• Alexander F, Matheson M, Fry NK, et al. Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease. Clin Vaccine Immunol 2012;19(11):1776-83
   PubMedGoogle Scholar
• Fine PE, Clarkson JA. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 1987;9(5):866-83
   PubMedGoogle Scholar
• Caro V, Elomaa A, Brun D, et al. Bordetella pertussis, Finland and France. Emerg Infect Dis 2006;12(6):987-9
   PubMedGoogle Scholar
• Tsang RS, Lau AK, Sill ML, et al. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol 2004;42(11):5364-7
   PubMedGoogle Scholar
• Kallonen T, Grondahl-Yli-Hannuksela K, Elomaa A, et al. Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infect Genet Evol 2011;11(8):2034-42
   PubMedGoogle Scholar
• Weber C, Boursaux-Eude C, Coralie G, et al. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J Clin Microbiol 2001;39(12):4396-403
   PubMed Web of Science ®Google Scholar
• Fine PE, Clarkson JA. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet 1982;1(8273):666-9
   PubMedGoogle Scholar
• Guiso N, Njamkepo E, Vie le Sage F, et al. Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Vaccine 2007;25(8):1390-7
   PubMed Web of Science ®Google Scholar
• Smallridge WE, Rolin OY, Jacobs NT, Harvill ET. Different effects of whole cell and acellular vaccines on Bordetella transmission. J Infect Dis 2014;209(12):1981-8
   PubMedGoogle Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2013;111(2):787-92
   PubMedGoogle Scholar
• Carlsson RM, Trollfors B. Control of pertussis--lessons learnt from a 10-year surveillance programme in Sweden. Vaccine 2009;27(42):5709-18
   PubMedGoogle Scholar
• Domenech de Celles M, Riolo MA, Magpantay FM, et al. Epidemiological evidence for herd immunity induced by acellular pertussis vaccines. Proc Natl Acad Sci U S A 2014;111(7):E716-17
   PubMed Web of Science ®Google Scholar
• Riedmann EM. Herd immunity protects babies against whooping cough. Hum Vaccin Immunother 2013;9(12):2501-2
   Google Scholar
• Ross PJ, Sutton CE, Higgins S, et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013;9(4):e1003264
   PubMed Web of Science ®Google Scholar
• Warfel JM, Beren J, Kelly VK, et al. Nonhuman primate model of pertussis. Infect Immun 2012;80(4):1530-6
   PubMed Web of Science ®Google Scholar
• Indian Academy of Pediatrics ACoV, Immunization P. Vashishtha VM, et al. Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years, India, 2013 and updates on immunization. Indian Pediatr 2013;50(12):1095-108
   PubMedGoogle Scholar
• Stefanoff P, Paradowska-Stankiewicz IA, Lipke M, et al. Incidence of pertussis in patients of general practitioners in Poland. Epidemiol Infect 2013;1-10
   Google Scholar